← Oncology Approval Tracker

FDA DECISION ·

Gefitinib (Iressa first generic)

gefitinib · Apotex

First generic approvalFirst genericNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First-line treatment of metastatic NSCLC with an EGFR exon 19 deletion or exon 21 substitution mutation.

LAMPGEN ANALYSIS

Why it matters

The first generic adds an option for an established EGFR-targeted drug in its defined first-line setting.

What research teams should watch

Confirm the specific EGFR variant and the selected tablet product in the prescribing workflow.

PRIMARY RECORDS

Sources